Skip to content
Trial Eligibility
Menu

White Matter Plasticity in Schizophrenia

NCT06641297

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Schizophrenia Disorders

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
15 to 45 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
University of Maryland, Baltimore
Last updated on ClinicalTrials.gov
February 20, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • Maryland Psychiatric Research Center · Catonsville, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.